Aashna Uppal1,2,3,4, Olivia Oxlade2,3, Ntwali Placide Nsengiyumva2,3, Dieynaba S N'Diaye1,2,3,4, Gonzalo G Alvarez5, Kevin Schwartzman6,7,8,9. 1. Montreal Chest Institute, Montreal, Quebec, Canada. 2. Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montreal, Quebec, Canada. 3. McGill International Tuberculosis Centre, 1001 boulevard Décarie, Room D05.2511, Montréal, Québec, H4A 3J1, Canada. 4. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada. 5. The Ottawa Hospital Research Institute, Department of Medicine, Division of Respirology, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada. 6. Montreal Chest Institute, Montreal, Quebec, Canada. kevin.schwartzman@mcgill.ca. 7. Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montreal, Quebec, Canada. kevin.schwartzman@mcgill.ca. 8. McGill International Tuberculosis Centre, 1001 boulevard Décarie, Room D05.2511, Montréal, Québec, H4A 3J1, Canada. kevin.schwartzman@mcgill.ca. 9. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada. kevin.schwartzman@mcgill.ca.
Abstract
BACKGROUND: Tuberculosis (TB) is an important public health problem in Inuit communities across Canada, with an annual incidence rate in 2017 that was nearly 300 times higher than in Canadian-born non-Indigenous individuals. Social and behavioral factors that are prevalent in the North, such as commercial tobacco use, excessive alcohol use, food insecurity and overcrowded housing put individuals at higher risk for TB morbidity and mortality. We examined the potential impact of mitigation strategies for these risk factors, in reducing TB burden in this setting. METHODS: We created a transmission model to simulate the epidemiology of TB in Nunavut, Canada. We then used a decision analysis model to assess the potential impact of several evidence-based strategies targeting tobacco use, excessive alcohol use, food insecurity and overcrowded housing. We predicted TB incidence, TB-related deaths, quality adjusted life years (QALYs), and associated costs and cost-effectiveness over 20 years. All costs were expressed in 2018 Canadian dollars. RESULTS: Compared to a status quo scenario with no new interventions for these risk factors, the reduction strategy for tobacco use was most effective and cost-effective, reducing TB incidence by 5.5% (95% uncertainty range: 2.7-11%) over 20 years, with an estimated cost of $95,835 per TB case prevented and $49,671 per QALY gained. The addition of the food insecurity reduction strategy reduced incidence by a further 2% (0.5-3%) compared to the tobacco cessation strategy alone, but at significant cost. CONCLUSIONS: Strategies that aim to reduce commercial tobacco use and improve food security will likely lead to modest reductions in TB morbidity and mortality. Although important for the communities, strategies that address excess alcohol use and overcrowding will likely have a more limited impact on TB-related outcomes at current scale, and are associated with much higher cost. Their benefits will be more substantial with scale up, which will also likely have important downstream impacts such as improved mental health, educational attainment and food security.
BACKGROUND:Tuberculosis (TB) is an important public health problem in Inuit communities across Canada, with an annual incidence rate in 2017 that was nearly 300 times higher than in Canadian-born non-Indigenous individuals. Social and behavioral factors that are prevalent in the North, such as commercial tobacco use, excessive alcohol use, food insecurity and overcrowded housing put individuals at higher risk for TB morbidity and mortality. We examined the potential impact of mitigation strategies for these risk factors, in reducing TB burden in this setting. METHODS: We created a transmission model to simulate the epidemiology of TB in Nunavut, Canada. We then used a decision analysis model to assess the potential impact of several evidence-based strategies targeting tobacco use, excessive alcohol use, food insecurity and overcrowded housing. We predicted TB incidence, TB-related deaths, quality adjusted life years (QALYs), and associated costs and cost-effectiveness over 20 years. All costs were expressed in 2018 Canadian dollars. RESULTS: Compared to a status quo scenario with no new interventions for these risk factors, the reduction strategy for tobacco use was most effective and cost-effective, reducing TB incidence by 5.5% (95% uncertainty range: 2.7-11%) over 20 years, with an estimated cost of $95,835 per TB case prevented and $49,671 per QALY gained. The addition of the food insecurity reduction strategy reduced incidence by a further 2% (0.5-3%) compared to the tobacco cessation strategy alone, but at significant cost. CONCLUSIONS: Strategies that aim to reduce commercial tobacco use and improve food security will likely lead to modest reductions in TB morbidity and mortality. Although important for the communities, strategies that address excess alcohol use and overcrowding will likely have a more limited impact on TB-related outcomes at current scale, and are associated with much higher cost. Their benefits will be more substantial with scale up, which will also likely have important downstream impacts such as improved mental health, educational attainment and food security.
Authors: Faiz Ahmad Khan; Greg J Fox; Robyn S Lee; Mylene Riva; Andrea Benedetti; Jean-François Proulx; Shelley Jung; Karen Hornby; Marcel A Behr; Dick Menzies Journal: CMAJ Open Date: 2016-09-16
Authors: Kianoush Dehghani; Zhiyi Lan; Peizhi Li; Sascha Wilk Michelsen; Sean Waites; Andrea Benedetti; Pierre Lejeune; Jill Torrie; Elizabeth Robinson; Berenica Vejvoda; Muhammad Mullah; Diana Redwood; Michael Cooper; Anne Fanning; Wadieh Yacoub; Gonzalo G Alvarez; Bolette Søborg; Richard Long; Dick Menzies Journal: Lancet Public Health Date: 2018-02-14
Authors: Maria Ruiz-Castell; Gina Muckle; Éric Dewailly; Joseph L Jacobson; Sandra W Jacobson; Pierre Ayotte; Mylène Riva Journal: Am J Public Health Date: 2015-01-20 Impact factor: 9.308
Authors: Edine W Tiemersma; Marieke J van der Werf; Martien W Borgdorff; Brian G Williams; Nico J D Nagelkerke Journal: PLoS One Date: 2011-04-04 Impact factor: 3.240
Authors: Anne Magnus; Linda Cobiac; Julie Brimblecombe; Mark Chatfield; Anthony Gunther; Megan Ferguson; Marj Moodie Journal: PLoS One Date: 2018-09-27 Impact factor: 3.240